The New England Journal - Journal Watch: Year in Review 2016
And Finally … Rounding Out Our Top 10: Additional notable 2016 studies
Editor: Allan S. Brett
Cardiovascular Outcomes with Newer Antidiabetes Drugs
Editor: Paul S. Mueller
Does CPAP Prevent Adverse CV Events in Patients with Obstructive Sleep Apnea?
Editor: Kirsten E. Fleischmann
Focus on Inappropriate Opioid Use Intensifies
Editor: Thomas L. Schwenk
New Sepsis-3 Definitions Await Confirmatory Data
Editor: Patricia Kritek
Pulmonary Embolism as a Cause of Syncope
Editor: Allan S. Brett
Racial Differences Persist in End-of-Life Care
Editor: Bruce Soloway
Randomized Comparison of Surgery, Radiotherapy, and Surveillance for Prostate Cancer
Editor: Allan S. Brett
With Oxygen, Could Less Be More?
Editor: Patricia Kritek
Zika Makes Headlines
Editor: Abigail Zuger, MD

Empagliflozin Is Associated with Fewer Adverse Renal Outcomes Voltar

Editor Associado: Allan S. Brett

Cardiovascular Outcomes with Newer Antidiabetes Drugs - Editor: Paul S. Mueller

Artigo Autor(es) Referência
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. Wanner Christoph, Inzucchi Silvio E, Lachin John M, Fitchett David, von Eynatten Maximilian, Mattheus Michaela, Johansen Odd Erik, Woerle Hans J, Broedl Uli C, Zinman Bernard, The New England journal of medicine. 2016 Jul; 375(Jul):323-34. doi: 10.1056/NEJMoa1515920. pii: .
Nenhuma revista foi definida para este congresso.